Related Experiment Video
Updated: Nov 2, 2025

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
Cardiac Abnormalities in COVID-19 Patients: Should a Cardiac Echocardiogram be Routine?
Carina Ramalho1, Mariana Almeida1, Francisco Gomes1
1Centro Hospitalar Barreiro Montijo, Barreiro, Portugal.
Insights
Patients with COVID-19 and heart failure face higher risks of left ventricular thrombi. Early echocardiography and anticoagulation treatment led to complete thrombus resolution and improved cardiac function in one case.
Area of Science:
- Cardiology
- Infectious Diseases
- Thrombosis
Background:
- Current evidence links SARS-CoV-2 infection to an elevated risk of thromboembolic events.
- Left ventricular thrombi in patients with ischemic heart disease and heart failure can lead to mortality via systemic embolization.
- The hypercoagulable state of COVID-19 may increase the likelihood of such thrombotic events.
Purpose of the Study:
- To highlight the potential for left ventricular thrombus formation in patients with both congestive heart failure and SARS-CoV-2 infection.
- To present a case demonstrating the diagnostic and therapeutic approach to intracardiac thrombus in this patient population.
Main Methods:
- Case report of a patient hospitalized with congestive heart failure and SARS-CoV-2 infection.
- Diagnosis of left ventricular thrombus confirmed via echocardiography.
- Treatment administered included anticoagulation therapy.
Main Results:
- Echocardiography identified a left ventricular thrombus in the patient.
- Following anticoagulation treatment, the thrombus completely resolved.
- The patient's cardiac function showed improvement after treatment.
Conclusions:
- SARS-CoV-2 infection is frequently associated with thromboembolic phenomena, including intracardiac thrombi.
- Echocardiographic assessment is crucial for patients with SARS-CoV-2 infection, particularly those with pre-existing or new cardiac conditions.
- Prompt diagnosis and treatment of intracardiac thrombi are vital for preventing complications and improving patient outcomes.
Abstract:
Current scientific evidence shows that SARS-CoV-2 infection is associated with an increased risk of thromboembolic events. In patients with ischaemic heart disease and heart failure, thrombi of the left ventricle can increase patient mortality, mainly due to the risk of systemic embolization. Given the hypercoagulable state associated with COVID-19, such events may be more likely. We describe a patient hospitalized for congestive heart failure and SARS-CoV-2 infection who was diagnosed with a thrombus in the left ventricle. After the thrombus was identified on echocardiography and treated with anticoagulation, it completely resolved and cardiac function improved.
Learning Points:
SARS-CoV-2 infection has been frequently associated with thromboembolic phenomena and intracardiac thrombi.Echocardiographic evaluation in patients with SARS-CoV-2 infection is important, especially in cases with known or new-onset cardiac pathology which predisposes to thromboembolic phenomena.The timely diagnosis and treatment of intracardiac thrombi can prevent complications and improve patient prognosis.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Related Concept Videos
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Dysrhythmias V: Evaluating Dysrhythmias
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization I: Pre-Procedure Overview
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies